key: cord-0967340-d91bi365
authors: Éva, Kállay; Medrea, Flavia; Csaba, Dégi László
title: On top of that all, now Covid-19, too. A scoping review of specificities and correlates of fear of cancer recurrence in breast cancer patients during COVID-19()
date: 2022-02-10
journal: Breast
DOI: 10.1016/j.breast.2022.02.007
sha: 75000552a9f169d507ddbf25b0793c9a64382047
doc_id: 967340
cord_uid: d91bi365

Fear of cancer recurrence (FCR) is a normal response in cancer survivors and one of the most prevalent reactions reported by up to 87% of them. However, elevated levels of FCR impair well-being, quality of life and professional functioning, and lead to anxiety, depression or PTSD. COVID-19 pandemic can exacerbate FCR symptoms, given the restricting access to follow-up investigations and treatment, the isolation restrictions imposed and the possibility of the medical system becoming overworked. This scoping review's objective was to synthesize the literature investigating the factors associated with higher levels of FCR in cancer survivors during the COVID-19 pandemic. The focus was on FCR in breast cancer patients, including most of the studies (5 out of 9) on this topic. However, given the novelty of the subject, the increased interest in it, and the fact that there are few studies in this field, the review included 4 other studies with mixed samples of patients with breast cancer and other oncological pathologies. Following rigorous methodological criteria, 9 studies with quantitative or mixed methodology were included (N = 4831 patients). The results indicate that high levels of FCR are associated with distress and concerns regarding the pandemic impact, with most common concerns of patients being changes in treatment plan (delays and interruptions), dysfunctional communication with medical staff or difficult access to food or medicine. The most common correlates of FCR during the pandemic are marital status, childlessness, low financial status, level of education, type of cancer diagnosis, generalized anxiety and depression.

Cancer-related diseases represent one of the leading causes of death before the age of 70, being also an important factor that lowers life expectancy in almost every country in the world (Sung et al., 2021; WHO, 2020) .

The diagnosis with cancer itself is usually considered an extremely stressful, potentially traumatic encounter (Costanzo et al., 2009; Kangas et al., 2002) . First and foremost, the multiple physical implications of the disease (the discomfort produced by the tumor treatment: surgery, radio and/or chemotherapy, acute and chronic pain, fatigue, lymphedema, etc.) (Ganz & Stanton, 2012) significantly affect the patients' well-being and quality of life (Grassi & Riba, 2012; Holland et al., 2013) . The impact of the diagnosis and treatment simultaneously affect the psychological, social, spiritual, professional functioning of the patients, and their proximal and distal environments as well (families, relatives, friends, co-workers, etc.) (Singer, 2018) . Over one-third of the patients in acute care present significant psychological disorders (e.g., anxiety, depression, adjustment disorders, posttraumatic stress-disorder) (Mehnert et al., 2014; Nakash et al., 2014) , and the associated social and economic cost are by no means negligible (Holecki et al., 2020) . In a considerable number of cases, the entire cancer-experience may be considered as a situation of multiple traumatic encounters in which the diagnosis would represent one of the traumatic factors.

Moreover, the entire cancer experience is infused with an emotion which constantly pendulates between background and foreground psychological states, namely, fear of cancer recurrence (FCR). FCR is usually defined as "fear, worry, or concern about cancer returning or progressing" (Lebel et al., 2016) [p. 3] .

FCR is a totally normal reaction to the threats involved in the complexity of aversive confrontations patients have to undergo since diagnosis (Dinkel & Herschbach, 2018) . Simard et al.'s (2013) systematic review indicates that regardless of the cancer type and assessment method, between 39% and 97% of cancer survivors reported varying degrees of FCR: 22% to 87% of the assessed patients indicated that have experienced moderate to high levels of FCR, and 0% to 15% reported experiencing high degrees of FCR.

FCR may appear at any stage of the illness trajectory, and may persist many years even after treatment or remission of illness, being relatively stable over time (Herschbach et al., 2005; J o u r n a l P r e -p r o o f Wagner et al., 2011) . One of the central aspects of FCR is the uncertainty of the prognostic, which, in many cases is significantly associated with maladaptive behavioral, emotional, and cognitive responses. These dysfunctional reactions are further associated with heightened levels of fear, worry, exaggerated vigilance regarding possible symptom recurrence or on the contrary, behavioral avoidance, etc. (Götze et al., 2019) .

Even if FCR shares some common characteristics with different anxiety disorders, it should be qualitatively differentiated from them, since in the case of oncological illnesses the threats are real, and the patients' fear cannot be considered as irrational, as is the situation in the case of neurotic anxiety disorders for example (Dinkel & Herschbach, 2018) .

So, to some degree FCR is a normal and adequate reaction to the physical and psychological challenges and uncertainties oncological patients must face after being diagnosed (Simonelli et al., 2017) . However, persistent, elevated levels of FCR may become a serious impediment in the face of adaptation, leading to dysfunctional reactions (Dinkel & Herschbach, 2018) .

Literature indicates that those cancer patients who experience high levels of FCR may experience additional maladaptive changes, as: impaired well-being, quality of life, and professional functioning; difficulties in making plans for the future; intrusive thinking; extremely frequent checking of different signs of cancer (hypochondria); excessive use of health care services; development of anxiety disorders; posttraumatic stress disorder; depression, etc. (Hart et al., 2008; Lasry & Margolese, 1992; Lebel et al., 2013; Thewes et al., 2013; van den Beuken-van Everdingen et al., 2008) . Furthermore, high levels of FCR may become a serious, chronic problem not only for the affected patients themselves , but may also negatively impact the life of their caregivers (Black & White, 2005) .

Since, worldwide, the majority of the cancer survivors consider that FCR is one of their most serious unmet need, it became imperative to identify those patients who are at risk to develop and maintain maladaptive levels of FCR, and to develop prevention and intervention strategies to reduce dysfunctional FCR (Crist & Grunfeld, 2013) .

A theoretic (Simonelli et al., 2017) and several systematic (Crist & Grunfeld, 2013; Simard et al., 2013) reviews conducted on this topic have identified essential risk factors that predispose some J o u r n a l P r e -p r o o f patients to experiencing higher levels of FCR, the most prevalent ones falling into the following categories: socio-demographic, physical and psychological.

Of the socio-demographic risk factors, younger age was found to be systematically associated with higher levels of FCR (Crist & Grunfeld, 2013; Simard et al., 2013; Simonelli et al., 2017) .

Studies investigating the importance of gender, level of education, marital status, income, ethnicity, and employment yielded mixed results regarding the development and maintenance of FCR (Crist & Grunfeld, 2013; Simard et al., 2013) . However, a number of studies found that female patients seem to be more prone to experience FCR than male cancer survivors (Crist & Grunfeld, 2013; Mehnert et al., 2009; Shay et al., 2016) .

Of the most frequently investigated physical factors related to FCR (e.g., time since diagnosis, site of cancer, severity, stage of illness, treatment type, type of surgery), strong evidence was found between high levels of FCR and presence/severity of physical symptoms, side-effects of treatment, pain, and receipt of chemotherapy (Crist & Grunfeld, 2013; Simard et al., 2013; Simonelli et al., 2017) . The investigation of the rest of the physical risk-factors produced mixed results.

Regarding psychological risk-factors, prior history of mental health problems, as previous exposure to traumatic situations (subclinical, clinical PTSD), different anxiety disorders, mood disorders emerged as stable risk factors for FCR (Simonelli et al., 2017) . Neuroticism was found to be strongly related to higher levels of FCR, while self-esteem, healthy coping, sense of coherence tended to lower FCR (Crist & Grunfeld, 2013; Simard et al., 2013; Simonelli et al., 2017) .

Moreover, exposure to media information, pending medical appointments, hearing of other people being also diagnosed with cancer, experiencing new or changing side-effects of the treatment or intensification of pain influences and increases reports of FCR (Crist & Grunfeld, 2013; Gill et al., 2004; Janz et al., 2011; van den Beuken-van Everdingen et al., 2008) .

Of utmost importance is the fact that the certainty of access to periodic follow-up examinations were reported to reduce the experience of FCR (Vickberg, 2003) , while disruption of access to healthcare services was found to increase worry and concerns about the progression and recurrence of the disease (Koral & Cirak, 2021) .

The 2019 coronavirus outbreak has massively changed human life all around the world. Due to its rapid spread, high levels of contagion and serious, multiple impact on human health, by the beginning of March 2020, the WHO had to declare COVID-19 a worldwide pandemic (Phelan et al., 2020; WHO, 2020) . Literature investigating human reactions during pandemics in general indicated that such multiple threats are usually accompanied by high levels of stress, anxiety, uncertainty, loneliness, confusion regarding one's and close ones' health, financial concerns, the possibility to lose loved ones, etc. could be considered as extremely stressful situations (Peteet, 2020; Taylor, 2017 Taylor, , 2019 .

In the general population, the already high levels of stress concerning the infection with COVID were aggravated by the conditions created by the quarantine. The isolation from family, friends, and co-workers, the permanent threat that health-care systems might be overwhelmed by the increasing number of infected patients, disruptions of usual life-routines, the negative psychological effect of the curfew, changing work habits (e.g., telework), etc. further aggravated the initial stressors, significantly affecting the populations' emotional and mental well-being (Brooks et al., 2020; Vergara-Buenaventura et al., 2020) .

The objective risk of contamination with the COVID-19 is significantly higher for cancer patients whose immunity is usually affected by either the disease itself or the afferent treatment (Gheorghe et al., 2021; Wang et al., 2020) .

If we take into consideration the specific situation of cancer survivors in normal life-conditions, it becomes obvious that the impact of the COVID-19 pandemic has further aggravated their already fragile situation. Knowing on the one hand that cancer has been a very serious independent risk factor for in-hospital mortality among patients diagnosed with cancer (de Azambuja et al., 2020) , and on the other hand that access to follow-ups and treatment was seriously restricted, it could be expected that FCR might have been exacerbated by the accumulating pandemic-induced emotional upheaval.

J o u r n a l P r e -p r o o f Thus, the major aim of the present paper was to review the currently available literature which examines factors that are associated with higher levels of FCR in breast cancer and other oncological pathologies survivors during the Covid-19 pandemic.

Based on the existing literature and taking into consideration the extremely large variety of types of cancer (NCI, 2021), each purporting different mortality and survival rates, physical, psychological, social, professional, etc. implications, we may consider that the stable risk factors in normal life conditions for increased FCR for most forms of cancer are: younger age, presence and severity of symptoms, side-effect of treatment, pain, treatment with chemotherapy, previous traumatic encounters, psychological disorders as: anxiety, mood disorders, and high levels of neuroticism. Moreover, disruptions in the access to health-care services, pending medical appointments, new or changing side-effects of treatment, intensification of pain may further exacerbate FCR (Crist & Grunfeld, 2013; Simard et al., 2013; Simonelli et al., 2017) .

Literature has also identified that higher levels of self-esteem, frequent use of different adaptive coping mechanisms, sense of coherence and certainty of access to periodic follow-ups have a benefic influence on the entire cancer experience, simultaneously reducing FCR (Crist & Grunfeld, 2013; Simard et al., 2013; Simonelli et al., 2017) .

In order to rigorously answer the present study's major objective, we opted to conduct a scoping review of the topic of FCR in breast cancer and other oncological pathologies survivors during the Covid-19 pandemic. The methodology of a scoping review offers the possibility to systematically map the literature investigating a specific issue (Gough et al., 2012) , and to summarize evidence, and identify possible knowledge gaps (Grant & Booth, 2009 ). According to Peters et al. (2020) , this type of investigation is very useful, when literature is characterized by high complexity and heterogeneity, which is the case of the topic selected by us to investigate. Moreover, the results of a scoping review may be highly informative for decision-makers by assisting the development of intervention agendas (Peters et al., 2020) .

The present review was conducted according to the PRISMA-ScR (Preferred Reporting Items for Systematic Reviews and Meta-Analyses extension for Scoping Reviews) guidelines appropriate J o u r n a l P r e -p r o o f for scoping reviews (Peters et al., 2020; Tricco et al., 2018 ). An electronic literature search was conducted in order to identify all studies published between January 2020 and up to 1 st of October 2021, across sources, including Web of Science, PubMed, Cochrane library, Medline, PsycINFO, Scopus, Science Direct. The time range was limited as related to the period of time of the COVID-19 pandemic, its beginning, and the moment when a sufficient number of studies have been published, so we could conduct a scoping review (1 st of October 2021). Terms associated with fear of cancer recurrence (FCR), worry of cancer recurrence, concern of cancer recurrence, fear of cancer progression, worry of cancer progression, and concern of cancer progression were selected.

References in the identified papers have also been checked and reviewed. The searches were conducted between 1 st of July and 1 st of October 2021.

Thus, in order to attain our research objective, we included in our review full-length articles published in international peer-reviewed journals, based on the following inclusion criteria:

• To be written in English

• To be published on the topic of fear of cancer recurrence (FCR) and fear of cancer progression (FCP) during the Covid-19 pandemic or sub-components of these concepts (fear, worry, concern of cancer recurrence or progress) (*Covid-19, *Corona-virus pandemic, *Sars-Cov-2)

• To include adult population of cancer survivors diagnosed with any type of cancer • To use quantitative or mixed methods of investigation • Review articles, book chapters, editorials, poster abstracts, case reports, commentaries, and dissertations were excluded

The selection process of the relevant literature of this scoping review is graphically presented in Figure 1 . The initial search with the above-presented key-words yielded 1808 studies. After removing studies that did not directly research the key-words of interest, we remained with 25 studies. After excluding 9 duplicate-studies we subjected to eligibility assessment 16 investigations, and after excluding 7 articles for not fulfilling the standards of methodological accuracy, we included in our scoping review 9 articles. Each of the 9 selected articles subjected to scoping review was assessed regarding its quality, by two independent reviewers regarding: country where the study was conducted, sample size, stage and type of cancer, type of study (qualitative, mixedqualitative studies were excluded), time since diagnosis, measures of fear of cancer recurrence/progression, results, factors/variables associated with FCR/FCP, possible biases and methodological limitations. Results are presented in Table 1 . Table 1 here

We have identified 9 studies that were published during the Covid-19 pandemic period up till the 1 st of October 2021. The 9 studies investigated a total number of 4,831cancer survivors during either in the first (2020) or the second (2021) J o u r n a l P r e -p r o o f differences have to be interpreted with caution because the previous study to which they compared their results involved older participants, the period of time between diagnosis and assessment was longer, and was conducted before the pandemic. According to this study, FCR was significantly higher among participants that were not married (F = 3.649, p = .028), childless (t = −2.043, p = .043) less financially potent participants (F = 4.259, p = .016) (Kim & Kim, 2021) .

A very important finding of this study is that unmarried, childless and less financially potent breast cancer survivors may be more prone to experience significantly higher levels of FCR due to the implications related to the Covid-19 pandemic (Kim & Kim, 2021) . (2021) (Massicotte et al., 2021) .

The study has several limitations, one of which being the extremely low number of participants and that it was conducted at the very beginning of the pandemic. The study also found a very strong inter-correlational pattern between perceived risk (concern), the perceived risk estimate (0-100%), and FCP (rs.64-0.69, p < 0.01) (Soriano et al., 2021) .

FCP was significantly associated with the following psychosocial variables: communication Differences due to surgery status indicated that survivors awaiting surgery also estimated that they 

The major limitations of this study were represented by the relatively small sample size, and by the fact that most participants were generally financially secure, highly educated, and did not report being severely impacted by the COVID-19 pandemic. survivors considered that oncological patients in general were exposed at higher risk to be infected with Covid-19, only 17.5% of them reported of being more afraid of a possible Covid-19 infection than being afraid of their oncological condition, and 53.1% were afraid that they might contract Covid-19 from health care sites, while receiving treatment for their oncological ailments.

Furthermore, according to the results of this study, the only risk factor found for higher levels of fear of Covid-19 than of fear related to the oncological diagnosis was age older than 70 years.

This study (Gultekin et al., 2021) The two open-ended questions also offered very interesting results regarding the fears and worries of gynecological cancer patients during the Covid-19 pandemic. The first question "What is the most challenging problem in this period?" was answered by 623 of the assessed participants in the study, 44% of which reported that the uncertainty produced by the Covid-19 and its implications represented a significant concern for them, while only 2% of the assessed patients reported worry due to possible financial concerns induced by the pandemic.

Regarding the second open-ended question "Message that you want told to share about COVID-19 pandemic with ESGO, ENGAGe and Other International Organizations", 65% of the respondents considered that it should be emphasized that cancer is more lethal than Covid-19, and that something should be done to better protect cancer patients. Summarizing the findings of this study (Gultekin et al., 2021) :

(1) Most cancer patients considered that having cancer was a major risk factor for contracting Covid-19, less than 1/5 of the assessed patients were more afraid of Covid-19 than cancer, and most of these patients were older than 70 years of age.

(2) Even if most of the assessed patients were afraid of the possibility of being infected with

Covid-19, their major concern remained the potential implications regarding the J o u r n a l P r e -p r o o f progression of their oncological disease due to the disruption of treatment, follow-ups etc.

during the pandemic.

However, this study also has some serious limitations, as: the assessment of FCR with one single item, which did not permit the establishment of low, medium and clinically significant levels of All of the patients who had completed treatment and were in remission (n = 134), reported some degree of FCR, 95% of them reporting clinical levels of FCR. Psychological distress and concern about the impact of COVID-19 on cancer management were found to be significantly associated with greater FCR during the pandemic among hematological cancer patients in remission, explaining 28% of variance in FCR (Zomerdijk et al., 2021) .

The major limitations of the present study were: potential bias due to the self-selection recruitment method, high heterogeneity of hematological cancer forms, did not examine the possible effect of medical care offered to some patients via telehealth.

Thus, this scoping review highlighted socio-demographic and psychological variables significantly associated with FCR during the COVID-19 pandemic. FCR was significantly higher among patients who were unmarried or without children, being negatively associated with monthly income (Kim & Kim, 2021) and educational level (Chen et al. 2020) , participants who generally were financially secure and highly educated did not report being severely impacted by the COVID-19 pandemic (Soriano et al., 2021) . However, Romanian cancer patients with lower income and higher education reported higher levels of concern about contracting Covid-19, suggesting that income and education may play an important role in the relationship dynamic between FCR and COVID-19 (Gheorghe et al. 2021) . Moreover, age was the only risk factor for higher levels of fear of Covid-19 than of fear related to the oncological diagnosis, patients older than 70 years being J o u r n a l P r e -p r o o f more concerned about COVID-19 than about their cancer progression (Gultekin et al., 2020) .

Some studies (Zomerdijk et al., 2021; Koral & Cirak, 2021) did not identify statistically significant differences in FCR depending on the assessed demographic variables, while others (Xie et al., 2021 , Massicotte et al., 2021 presented limited information regarding results about the investigated demographic variables.

Regarding psychological variables significantly associated with FCR during the COVID-19

pandemic, higher levels of concerns regarding the implication of the pandemic were significantly associated with FCR, anxiety, depression, and insomnia (Massicotte et al., 2021) . Other studies found correlations between FCR and satisfaction with the quality of communication with the medical staff, perceived risk, impaired sleep quality and quality of life (Soriano et al., 2021) , and elevated levels of anxiety and depression (Chen et al., 2020; Gultekin et al., 2020; Xie et al., 2021) .

Therefore, almost all studies included identified elevated levels of FCR during the COVID-19

pandemic (Zomerdijk et al., 2021) , with patients also reporting fear, unmet needs and psychological distress about the impact of COVID-19 in the management of the oncological treatment. Moreover, beside concerns about negatively-impacted cancer treatment trajectory, patients fear both the evolution of the cancer and a possible infection with Covid-19 (Gheorghe et al., 2021) , psychological distress about the impact of COVID-19 on cancer management being associated with greater FCR during the pandemic, explaining 28% of variance in FCR (Zomerdijk et al., 2021) .

As we have seen in the introductory part of this paper, the diagnosis with cancer, and the considerably changed life-conditions seriously impact most oncological patient's life. FCR can be problematic well into the years after cancer has been successfully treated (Stanton, 2006) , and frequently accompanies the unfolding of the (mal)adaptive oncological survivorship trajectory (Götze et al., 2019 (Kim & Kim, 2021) , education level (patients with lower levels of education experienced significantly higher levels of FCR), lower income, cancer diagnosis (patients J o u r n a l P r e -p r o o f diagnosed with lung cancer experienced higher levels of FCR) (Chen et al., 2020) , resilience and spiritual well-being proved to be protective factors in the development of FCR (Koral & Cirak, 2021) , generalized anxiety, depression, sleep quality, quality of life (Soriano et al., 2021) , quality of emotional and social life (Xie et al., 2021) , psychological distress and concern regarding the impact of Covid-19 on cancer management (Zomerdijk et al., 2021) .

A Bandinelli et al.'s (2021) study states, in the case of cancer patients during the Covid-19

pandemic we can speak not of clearly-delimited, well-defined types of anxieties and fears. But of a sum of fears, that overlap, and potentially potentate each other (Bandinelli et al., 2021) .

Summarizing, studies show that FCR is associated with dysfunctional reactions, impaired wellbeing, quality of life and professional functioning, anxiety, depression and posttraumatic stress disorders (Lebel et al., 2013; Thewes et al., 2013) . The COVID-19 pandemic can exacerbate the already existing FCR in cancer patients, given the access restrictions to follow-up and treatment, the isolation restrictions imposed and the possibility that the medical system becomes overworked.

Therefore, the treatment's trajectory, investigations, and the psychological health of people suffering from breast cancer are negatively affected during these times. Based on the studies presented in this scoping review, during this pandemic period, FCR is correlated with cancer patients' concerns about possible delays or interruptions in treatment plans and about dysfunctional communication with medical staff (Soriano et al., 2021) . Studies identified elevated levels of FCR during the COVID-19 pandemic, as well as elevated levels of anxiety and depression (Gultekin et al., 2020; Massicote et al., 2021; Xie et al., 2021) . The COVID-19 pandemic is a context that may worsen the already existing FCR, cancer patients reporting now additional psychological distress about a possible infection with the virus besides the fear related to cancer evolution during this period (Gheorghe et al., 2021; Zomerdijk et al., 2021) .

Scoping reviews often lay ground for more complex analyses on a topic (e.g., systematic reviews, meta-analyses) in situations when such investigations do not yet exist. They offer the possibility to systematically map the literature investigating a specific issue (Gough et al., 2012) , and to summarize evidence, and identify possible knowledge gaps (Grant & Booth, 2009 ). Nevertheless, scoping reviews have their limitations that have to be taken into account. First of all, they usually review a broad research topic, which may lead to similarly broad findings (Hanneke, Asada, Lieberman, Neubauer, & Fagen, 2017) . Another limitation is that they do not qualitatively assess the included studies (Grant & Booth, 2009 Glinder et al., 2007) . Hospital study results revealed that both high-fearful and low-fearful breast cancer survivors showed more interference by cancer words than the healthy controls indicating that the specific type of metacognitive thinking underlying fear of cancer recurrence may be more akin to anxiety disorder . In addition, an intervention program targeting cognitive bias modification for fear of cancer recurrence in breast cancer survivors, adapting a program initially developed for anxiety disorders, has shown limited preliminary efficacy (Lichtenthal et al., 2017) . Other studies reported inconsistent data with no clear evidence of attention biases associated with fear of cancer recurrence, suggesting that care should be taken in applying such treatment components in clinical cancer care (Butow et al., 2014) . We propose that future studies investigating FCR invest significant attention in the study of these factors.

Since the future evolution of the pandemic is highly uncertain worldwide, the aggravation of the mental health state of breast cancer and other oncological pathologies survivors during the pandemic should become an issue of crucial importance for all levels of health care services. The immediacy with which the concerted efforts of medical stuff and mental-health care practitioners address FCR and FCP during the Covid-19 period (e.g., facilitation of access to medical care, the maintenance of normal treatment schedules, increased access to mental health care practitioners, financial help for persons with low financial status, etc.) would not only alleviate clinical and/or psychological/psychiatric symptoms but also increase cancer survivorship. 

The Sum of Fears in Cancer Patients Inside the Context of the COVID-19

Fear of recurrence, sense of coherence and posttraumatic stress disorder in hematological cancer survivors

The psychological impact of quarantine and how to reduce it: rapid review of the evidence

Attentional bias and metacognitions in cancer survivors with high fear of cancer recurrence

Fear of disease progression and psychological stress in cancer patients under the outbreak of COVID-19

Psychosocial adjustment among cancer survivors: findings from a national survey of health and well-being. Health psychology : official journal of the Division of Health Psychology

Factors reported to influence fear of recurrence in cancer patients: a systematic review

Selective Attention and Fear of Cancer Recurrence in Breast Cancer Survivors

The Cancer Worry Scale: Detecting Fear of Recurrence in Breast Cancer Survivors

Impact of solid cancer on in-hospital mortality overall and among different subgroups of patients with COVID-19: a nationwide, populationbased analysis

A computerized Stroop task to assess cancer-related cognitive biases

Fear of progression in cancer patients and survivors

Psychosocial and physical health in post-treatment and extended cancer survivorship. Clinical psycho-oncology: an international perspective

Knowledge, attitudes and practices related to the COVID-19 outbreak among Romanian adults with cancer: a cross-sectional national survey

Triggers of uncertainty about recurrence and long-term treatment side effects in older African American and Caucasian breast cancer survivors

Psychological adjustment to breast cancer: Automatic and controlled responses to stress

Fear of cancer recurrence across the survivorship trajectory: Results from a survey of adult longterm cancer survivors

Clarifying differences between review designs and methods

A typology of reviews: an analysis of 14 review types and associated methodologies

Introducing multicultural psycho-oncology

Perspectives, fears and expectations of patients with gynaecological cancers during the COVID-19 pandemic: A Pan-European study of the European Network of Gynaecological Cancer Advocacy Groups (ENGAGe)

The scoping review method: Mapping the literature in "structural change" public health interventions

Fear of recurrence, treatment satisfaction, and quality of life after radical prostatectomy for prostate cancer

Fear of progression in chronic diseases: psychometric properties of the Fear of Progression Questionnaire

Oncological Diseases and Social Costs Considerations on Undertaken Health Policy Interventions

Correlates of worry about recurrence in a multiethnic population-based sample of women with breast cancer

Posttraumatic stress disorder following cancer: A conceptual and empirical review

Do COVID-19-Related Treatment Changes Influence Fear of Cancer Recurrence, Anxiety, and Depression in Breast Cancer Patients? Cancer Nursing

Fear of recurrence and disease progression in long-term (≥5 years) cancer survivors-a systematic review of quantitative studies

The relationships between fear of cancer recurrence, spiritual well-being and psychological resilience in non-metastatic breast cancer survivors during the COVID-19 outbreak

Fear of recurrence, breast-conserving surgery, and the trade-off hypothesis

From normal response to clinical problem: definition and clinical features of fear of cancer recurrence

Does fear of cancer recurrence predict cancer survivors' health care use? Supportive Care in Cancer

A pilot randomized controlled trial of cognitive bias modification to reduce fear of breast cancer recurrence

COVID-19 Pandemic Stressors and Psychological Symptoms in Breast Cancer Patients

Fear of cancer progression and cancer-related intrusive cognitions in breast cancer survivors

Four-Week Prevalence of Mental Disorders in Patients With Cancer Across Major Tumor Entities

Comorbidity of common mental disorders with cancer and their treatment gap: findings from the World Mental Health Surveys

Types of Cancer. National Cancer Institute

COVID-19 Anxiety

Updated methodological guidance for the conduct of scoping reviews

The novel coronavirus originating in Wuhan, China: challenges for global health governance

/11/01). Prevalence and correlates of fear of recurrence among adolescent and young adult versus older adult post-treatment cancer survivors

Fear of cancer recurrence in adult cancer survivors: a systematic review of quantitative studies

Fear of cancer recurrence: a theoretical review and its relevance for clinical presentation and management

Psychosocial impact of cancer

Psychosocial Impact of Cancer Care Disruptions in Women With Breast Cancer During the COVID-19 Pandemic

Psychosocial Concerns and Interventions for Cancer Survivors

Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries

COVID-19 Lockdown and Its Adverse Impact on Psychological Health in Breast Cancer

Clinician's guide to PTSD: A cognitive-behavioral approach

The psychology of pandemics: Preparing for the next global outbreak of infectious disease

Psychological morbidity and stress but not social factors influence level of fear of cancer recurrence in young women with early breast cancer: results of a cross-sectional study

PRISMA Extension for Scoping Reviews (PRISMA-ScR): Checklist and Explanation

Concerns of former breast cancer patients about disease recurrence: a validation and prevalence study

The Mental Health Consequences of Coronavirus Disease 2019 Pandemic in Dentistry

The concerns about recurrence scale (CARS): A systematic measure of women's fears about the possibility of breast cancer recurrence

Randomized clinical trial to evaluate an e-health intervention for fear of cancer recurrence, anxiety, and depression among cancer survivors

Does comorbidity increase the risk of patients with COVID-19: evidence from meta-analysis

Global Health Estimates 2020: Deaths by Cause, Age, Sex, by Country and by Region

Predictors for Fear of Cancer Recurrence in Breast Cancer Patients Referred to Radiation Therapy During the COVID-19 Pandemic: A Multi-Center Cross-Section Survey

Prevalence and correlates of psychological distress, unmet supportive care needs, and fear of cancer recurrence among haematological cancer patients during the COVID-19 pandemic

Inclusion criteria (a) non-metastatic breast cancer diagnosis, (b) scheduled to receive chemotherapy in the upcoming days/weeks, (c) between 18 and 80 years of age, and (d) able to read and understand French help or social support) plus 1 -item possibility to contract Covid-19 2items regarding the possibility that cancer may progress or be less likely to be cured due to changes in cancer treatment implication of Covid-10 pandemic was significantly associated with FCR, anxiety, depression, and insomnia.  High levels of FCR are associated with distress and concerns regarding the impact of the pandemic. The most common concerns indicated by patients are: changes in treatment plan (delays and interruptions), dysfunctional communication with medical staff, and difficult access to food or medicine. The most common correlates of FCR during the pandemic are marital status, childlessness, low financial status, level of education, type of cancer diagnosis, generalized anxiety and depression.